FASIHA KANWAL to Mass Screening
This is a "connection" page, showing publications FASIHA KANWAL has written about Mass Screening.
Connection Strength
2.204
-
The HCV Treatment Cascade: Race Is a Factor to Consider. J Gen Intern Med. 2019 10; 34(10):1949-1951.
Score: 0.434
-
Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan. JAMA Netw Open. 2019 05 03; 2(5):e193613.
Score: 0.421
-
A Randomized Trial of Off-Site Collaborative Care for Depression in Chronic Hepatitis C Virus. Health Serv Res. 2018 08; 53(4):2547-2566.
Score: 0.376
-
CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. Gastroenterology. 2013 Mar; 144(3):478-81.
Score: 0.275
-
CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):200-3.
Score: 0.275
-
Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study. BMJ Open. 2019 06 11; 9(6):e026726.
Score: 0.106
-
Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System. BMC Med Res Methodol. 2018 01 04; 18(1):1.
Score: 0.096
-
Screening high risk individuals for hepatitis B: physician knowledge, attitudes, and beliefs. Dig Dis Sci. 2011 Dec; 56(12):3471-87.
Score: 0.062
-
Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med. 2011 Jan 18; 154(2):85-93.
Score: 0.059
-
Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients. JAMA Netw Open. 2024 04 01; 7(4):e248755.
Score: 0.037
-
Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda. Clin Gastroenterol Hepatol. 2022 01; 20(1):9-18.
Score: 0.029
-
Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis. Hepatology. 2018 07; 68(1):7-9.
Score: 0.025
-
Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl. 2003 Jul; 9(7):672-81.
Score: 0.009